A transgenic model of AD expressing the three genetic mutations of amyloid precursor protein (APP), Presenilin-1 and tau associated with familial AD (APPSwe, PS1M146V and tauP301L) showed decreased nocturnal activity and increased daytime activity, with shorter free-running periods14. The gene discussed is MAPT; the disease is Alzheimer disease.